ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 173 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2019. The put-call ratio across all filers is 6.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $3,580,000 | -12.7% | 39,700 | -7.7% | 0.21% | -34.1% |
| Q2 2021 | $4,100,000 | -45.4% | 43,000 | -34.8% | 0.32% | -50.5% |
| Q1 2021 | $7,515,000 | -39.0% | 66,000 | -25.8% | 0.65% | -32.4% |
| Q4 2020 | $12,319,000 | +90.7% | 89,000 | +13.2% | 0.96% | +82.4% |
| Q3 2020 | $6,460,000 | +4.5% | 78,600 | -0.5% | 0.53% | -33.8% |
| Q2 2020 | $6,180,000 | +261.2% | 79,000 | +105.2% | 0.80% | +143.6% |
| Q1 2020 | $1,711,000 | +640.7% | 38,500 | +612.7% | 0.33% | +628.9% |
| Q4 2019 | $231,000 | -87.0% | 5,402 | -80.7% | 0.04% | -87.1% |
| Q2 2019 | $1,778,000 | +66.9% | 28,000 | +169.2% | 0.35% | -27.3% |
| Q2 2015 | $1,065,000 | – | 10,400 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 437,512 | $31,772,000 | 2.80% |
| RTW INVESTMENTS, LP | 1,373,284 | $99,728,000 | 2.06% |
| Rock Springs Capital Management LP | 1,028,109 | $74,661,000 | 1.88% |
| Privium Fund Management B.V. | 112,727 | $8,186,000 | 1.81% |
| Avidity Partners Management LP | 869,000 | $63,107,000 | 1.31% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 525,100 | $38,133,000 | 1.16% |
| Boxer Capital, LLC | 200,000 | $14,524,000 | 0.75% |
| SECTOR GAMMA AS | 46,221 | $3,357,000 | 0.73% |
| FEDERATED HERMES, INC. | 3,987,728 | $289,589,000 | 0.65% |
| EMERALD ADVISERS, LLC | 223,952 | $16,263,000 | 0.62% |